-- Cipher Pharmaceuticals（CPH.TO）週五表示，多倫多證券交易所已接受其回購至多150萬股股票的意向通知。 聲明稱，正常發行人回購計畫（NCIB）將於5月5日開始，為期一年。 根據Cipher目前的NCIB（將於5月4日到期），該公司以平均每股13.90美元的價格回購了532,940股股票。 週四，Cipher Pharmaceuticals的股票在多倫多證券交易所收盤下跌0.39美元，報17.71美元。
Related Articles
International
April S&P Global US Final Manufacturing PMI 54.5 Vs. Unrevised Expected 54.0 Flash, March 52.3
Australia
UBS Adjusts Price Target on LPL Financial to $395 From $380, Maintains Buy Rating
LPL Financial (LPLA) has an average rating of overweight and mean price target of $403, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $320.57, Change: $-13.56, Percent Change: -4.06%
$LPLA
Australia
Morgan Stanley Adjusts Trane Technologies PT to $565 From $535, Maintains Overweight Rating
Trane Technologies (TT) has an average rating of overweight and mean price target of $512.79, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $494.72, Change: $+2.41, Percent Change: +0.49%
$TT